Lv7
4120 积分 2021-03-30 加入
Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Iberdomide
1小时前
待确认
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects
1小时前
待确认
Mezigdomide and Multiple Myeloma
2小时前
待确认
A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
2小时前
待确认
Mezigdomide for multiple myeloma: a focus on phase 2 trial data
3小时前
待确认
Application of Physiologically Based Pharmacokinetic Modeling to Inform Dose Selection of Mezigdomide in a Phase I Drug–Drug Interaction Study
3小时前
待确认
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden
3小时前
待确认
Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse
4小时前
待确认
Cereblon-Targeting Ligase Degraders in Myeloma
4小时前
待确认
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
2天前
已完结
皖公网安备34019202002308
